| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $2.6M | -63.6% |
| SG&A Expense | $6.1M | -21.8% |
| Operating Income | -$8.8M | +42.0% |
| Pre-tax Income | -$8.8M | +37.0% |
| Income Tax | -$96K | -4.3% |
| Net Income | -$11.1M | +47.1% |
| EPS (Basic) | -$0.28 | +48.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.9M | -62.6% |
| Current Assets | $28.6M | +55.1% |
| Total Assets | $34.3M | +38.3% |
| Current Liabilities | $11.0M | +38.4% |
| Total Liabilities | $48.6M | +0.7% |
| Stockholders' Equity | -$32.9M | -22.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.4M | +0.2% |
| Capital Expenditures | $224K | +124.0% |
| Investing Cash Flow | -$12.0M | — |
| Financing Cash Flow | $26.8M | — |
| Free Cash Flow | -$16.7M | -0.6% |